Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS)

NCT04347967 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Respiratory Distress Syndrome

Interventions

BIOLOGICAL: UMC119-06

Sponsor

Meridigen Biotech Co., Ltd.